These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 7545499)
61. Cellular and humoral immune responses of a patient with American cutaneous leishmaniasis and AIDS. Da-Cruz AM; Machado ES; Menezes JA; Rutowitsch MS; Coutinho SG Trans R Soc Trop Med Hyg; 1992; 86(5):511-2. PubMed ID: 1475817 [TBL] [Abstract][Full Text] [Related]
62. Leishmania mexicana in C3H mice: BCG and levamisole treatment of established infections. Grimaldi GF; Moriearty PL; Hoff R Clin Exp Immunol; 1980 Aug; 41(2):237-42. PubMed ID: 7438553 [TBL] [Abstract][Full Text] [Related]
63. Monocyte suppression of antigen-specific lymphocyte responses in diffuse cutaneous leishmaniasis patients from the Dominican Republic. Petersen EA; Neva FA; Barral A; Correa-Coronas R; Bogaert-Diaz H; Martinez D; Ward FE J Immunol; 1984 May; 132(5):2603-6. PubMed ID: 6201552 [TBL] [Abstract][Full Text] [Related]
64. Leishmania braziliensis guyanensis dermal leishmaniasis: cell-mediated immunity related to clinical features. Barbier D; Goyot P; Dedet JP Trans R Soc Trop Med Hyg; 1985; 79(1):47-50. PubMed ID: 3887683 [TBL] [Abstract][Full Text] [Related]
65. Potential antigenic targets used in immunological tests for diagnosis of tegumentary leishmaniasis: A systematic review. Freire ML; Rêgo FD; Cota G; Pascoal-Xavier MA; Oliveira E PLoS One; 2021; 16(5):e0251956. PubMed ID: 34043671 [TBL] [Abstract][Full Text] [Related]
67. T-cell responses to infected autologous monocytes in patients with cutaneous and mucocutaneous leishmaniasis. Cooper AM; Melby PC; Karp CL; Neva F; Sacks DL Clin Diagn Lab Immunol; 1994 May; 1(3):304-9. PubMed ID: 7496967 [TBL] [Abstract][Full Text] [Related]
68. Immunotherapy of american cutaneous leishmaniasis in Venezuela during the period 1990-99. Convit J; Ulrich M; Zerpa O; Borges R; Aranzazu N; Valera M; Villarroel H; Zapata Z; Tomedes I Trans R Soc Trop Med Hyg; 2003; 97(4):469-72. PubMed ID: 15259484 [TBL] [Abstract][Full Text] [Related]
69. Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review. Silveira FT; Lainson R; Corbett CE Mem Inst Oswaldo Cruz; 2004 May; 99(3):239-51. PubMed ID: 15273794 [TBL] [Abstract][Full Text] [Related]
70. Frequency of Leishmania-reactive T cells in lesions of American mucocutaneous leishmaniasis (AMCL) patients. Its relevance in the process of healing or aggravation of the disease. Conceição-Silva F; Dórea R; Pirmez C; Schubach AO; Cysne L; Coutinho SG Mem Inst Oswaldo Cruz; 1988 Nov; 83 Suppl 1():403-6. PubMed ID: 3267032 [No Abstract] [Full Text] [Related]
72. Leishmania amazonensis: the Asian rhesus macaques (Macaca mulatta) as an experimental model for study of cutaneous leishmaniasis. Amaral VF; Ransatto VA; Conceicão-Silva F; Molinaro E; Ferreira V; Coutinho SG; McMahon-Pratt D; Grimaldi G Exp Parasitol; 1996 Jan; 82(1):34-44. PubMed ID: 8617329 [TBL] [Abstract][Full Text] [Related]
73. Depression of lymphocyte activity during cutaneous leishmaniasis: a case report. Matera G; Torti C; Mazzitelli M; Greco G; Rania A; Peronace C; Settembre P; Galati L; Giancotti A; Lamberti AG; Barreca GS; Rossi M; Quirino A; Liberto MC; Focà A Diagn Microbiol Infect Dis; 2018 Nov; 92(3):230-234. PubMed ID: 29950279 [TBL] [Abstract][Full Text] [Related]
74. Comparative study of American cutaneous leishmaniasis and diffuse cutaneous leishmaniasis in two strains of inbred mice. Pérez H; Arredondo B; González M Infect Immun; 1978 Nov; 22(2):301-7. PubMed ID: 730354 [TBL] [Abstract][Full Text] [Related]
75. Characterization of the cellular immune response in American cutaneous leishmaniasis. Castes M; Agnelli A; Verde O; Rondón AJ Clin Immunol Immunopathol; 1983 May; 27(2):176-86. PubMed ID: 6409480 [TBL] [Abstract][Full Text] [Related]
76. P 53 suppressor gene and cathepsin D expression in correlation with cellular and humoral immunity in cutaneous leishmaniasis. Selim MA; Nada SM; Abaza BE; Selim AG; Mangoud AM; Ramadan ME; Morsy TA J Egypt Soc Parasitol; 1996 Dec; 26(3):743-53. PubMed ID: 8918047 [TBL] [Abstract][Full Text] [Related]
77. [Histology of cutaneous leishmaniasis]. Mokni M; Mebazaa A; Boubaker S Ann Dermatol Venereol; 2011; 138(4):354-6. PubMed ID: 21497266 [No Abstract] [Full Text] [Related]
78. The flow-cytometry-based evaluation of cellular immunity in cases of cutaneous leishmaniasis and healthy controls from the endemic area in southern Israel. Fishman D; Bazarsky E; Sneir R; Klement E; Orr N; Kayouf R; Segal S; El-On J Ann Trop Med Parasitol; 2006 Jan; 100(1):23-31. PubMed ID: 16417710 [TBL] [Abstract][Full Text] [Related]
79. Diffuse cutaneous leishmaniasis in Ethiopia. 3. Immunological studies. IV. Pathogenesis of diffuse cutaneous leishmaniasis. Bryceson AD Trans R Soc Trop Med Hyg; 1970; 64(3):380-93. PubMed ID: 4195254 [No Abstract] [Full Text] [Related]
80. Serum antibody specificities to Leishmania aethiopica antigens in patients with localized and diffuse cutaneous leishmaniasis. Mengistu G; Akuffo HO; Yemane-Berhan T; Britton S; Fehniger TE Parasite Immunol; 1990 Sep; 12(5):495-507. PubMed ID: 2255561 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]